QuidelOrtho Corporation (LON:0A55)
43.50
-0.14 (-0.31%)
Jan 31, 2025, 6:48 PM GMT
QuidelOrtho Employees
QuidelOrtho had 6,600 employees as of December 29, 2024. The number of employees decreased by 500 or -7.04% compared to the previous year.
Employees
6,600
Change (1Y)
-500
Growth (1Y)
-7.04%
Revenue / Employee
306.75K GBP
Profits / Employee
-127.16K GBP
Market Cap
1.18B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 29, 2024 | 6,600 | -500 | -7.04% |
| Dec 31, 2023 | 7,100 | 100 | 1.43% |
| Jan 1, 2023 | 7,000 | 5,400 | 337.50% |
| Jul 3, 2022 | 6,900 | - | - |
| Jan 2, 2022 | 1,600 | 230 | 16.79% |
| Dec 31, 2020 | 1,370 | 120 | 9.60% |
| Dec 31, 2019 | 1,250 | 26 | 2.12% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Spire Healthcare Group | 15,703 |
| CVS Group | 8,850 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,780 |
QuidelOrtho News
- 4 weeks ago - Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - Nasdaq
- 7 weeks ago - Notable Two Hundred Day Moving Average Cross - QDEL - Nasdaq
- 2 months ago - Innovating Diagnostics and What's Next - PRNewsWire
- 2 months ago - Insider Buying: Ann Rhoads Acquires Shares of QuidelOrtho Corp (QDEL) - GuruFocus
- 2 months ago - Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs - The Motley Fool
- 2 months ago - QuidelOrtho Corp at Citi Global Healthcare Conference Transcript - GuruFocus
- 2 months ago - QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Monday 11/24 Insider Buying Report: QDEL, MTCH - Nasdaq